Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-017-1673-6
Abstract: PurposeFavorable long-term outcomes of the Zilver PTX drug-eluting stent (DES) in femoropopliteal lesions have been demonstrated. Chronic renal failure (CRF) has been shown to be a risk factor for restenosis and decreased limb salvage. The… read more here.
Keywords: without crf; study; patients crf; market surveillance ... See more keywords
E-019 Initial post market experience with the pulserider intracranial stent
Sign Up to like & getrecommendations! Published in 2018 at "Journal of NeuroInterventional Surgery"
DOI: 10.1136/neurintsurg-2018-snis.95
Abstract: Purpose To show a two-centers initial post market experience with the use of a new intracranial stent specially designed for wide neck bifurcation aneurysm. Materials and methods We retrospectively reviewed 6 consecutive cases of elective… read more here.
Keywords: intracranial stent; post; market experience; initial post ... See more keywords
Intracranial aneurysms managed by parent artery reconstruction using Tubridge: Study protocol for a prospective, multicenter, post-market clinical trial
Sign Up to like & getrecommendations! Published in 2020 at "Interventional Neuroradiology"
DOI: 10.1177/1591019920976233
Abstract: Background As a new endovascular reconstruction technique, flow diverter (FD) shows excellent efficacy and safety for treatment of intracranial aneurysms. In a previous multicenter, randomized, controlled, pre-market study, Tubridge FD showed remarkably higher complete occlusion… read more here.
Keywords: multicenter; trial; intracranial aneurysms; market ... See more keywords
Evaluating Post-Market Adverse Events of The New Hepatitis C Therapies Using FEARS Data
Sign Up to like & getrecommendations! Published in 2022 at "Healthcare"
DOI: 10.3390/healthcare10081400
Abstract: Background: Little is known regarding the safety of direct-acting antivirals (DAA), even though they are widely used. This study aims to evaluate the adverse events of DAA using post-market data. Methods: FDA Adverse Events Reporting… read more here.
Keywords: reported using; post market; adverse events; using harvoni ... See more keywords